NCT05644106

Brief Summary

Interest and demand for sound amplifiers are increasing due to the burden of purchasing hearing aids and technological advances in healthcare products, and the demand is expected to increase rapidly. For sensorineural hearing loss patients, who are subject to wearing hearing aids, it aims to compare the effect of hearing aid application and personal sound amplification product (PSAPs) compared to the hearing aids

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 10, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2021

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

November 21, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

December 9, 2022

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 9, 2023

Completed
Last Updated

December 9, 2022

Status Verified

December 1, 2022

Enrollment Period

1 month

First QC Date

November 21, 2022

Last Update Submit

December 1, 2022

Conditions

Keywords

Hearing aid, Personal sound amplification product, Hearing aid application, Hearing loss

Outcome Measures

Primary Outcomes (1)

  • The hearing level threshold (decibel) after each treatment

    The comparison of hearing threshold, which is calculated as mean decibel on four frequencies, among different treatments

    1 month

Study Arms (2)

Unaided

ACTIVE COMPARATOR
Device: personal sound amplification product, hearing aid

Aided

ACTIVE COMPARATOR
Device: personal sound amplification product, hearing aid

Interventions

the device for hearing gain in sensorineural hearing loss

AidedUnaided

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults over the age of 20 who speak Korean as their mother tongue and have no mental or physical limitations in conducting test.
  • Hearing loss patients with a hearing threshold of 26 dB or higher in the four frequency (0.5, 1, 2, 4 kHz)
  • Those who do not have a history of neurological disease, cognitive disorder, learning disorder, or language disorder at the time of recruitment

You may not qualify if:

  • In case that communication is difficult, equipment cannot be handled, or it is difficult to cooperate with the inspection
  • Acoustic nerve lesions or central nervous system disease
  • Those suspected of having false hearing loss
  • Those who have secondary benefits related to clinical trials

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, 110-744, South Korea

RECRUITING

Related Publications (1)

  • Jo S, Park MK, Seo JH, Lee KE, Han JS, Lim JH, Lee JH, Oh SH. Feasibility of a Smartphone-Based Hearing Aid App for Mild-to-Moderate Hearing Loss: Prospective Multicenter Randomized Controlled Trial. JMIR Mhealth Uhealth. 2023 Oct 5;11:e46911. doi: 10.2196/46911.

MeSH Terms

Conditions

Hearing DisordersHearing Loss

Interventions

Hearing Aids

Condition Hierarchy (Ancestors)

Ear DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Wearable Electronic DevicesElectrical Equipment and SuppliesEquipment and SuppliesSensory Aids

Central Study Contacts

Moo Kyun Park, M.D., Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 21, 2022

First Posted

December 9, 2022

Study Start

August 10, 2021

Primary Completion

September 10, 2021

Study Completion

August 9, 2023

Last Updated

December 9, 2022

Record last verified: 2022-12

Locations